Forte Biosciences, Inc. Common Stock
Symbol: FBRX (NASDAQ)
14.35
▼ (-7.36%) -1.140
Company Description:
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
Key Stats
- Today's Open: $15.025
- Today's High: $15.65
- Today's Low: $14.166
- Today's Volume: 101.48K
- Yesterday Close: $15.49
- Yesterday High: $15.49
- Yesterday Low: $13.41
- Yesterday Volume: 65.24K
- Last Min Volume: 38
- Last Min High: $14.35
- Last Min Low: $14.35
- Last Min VWAP: $14.35
Company Profile
- Name: Forte Biosciences, Inc. Common Stock
- Website: https://www.fortebiorx.com
- Listed Date: 2020-06-16
- Location: DALLAS, TX
- Market Status: Active
- CIK Number: 0001419041
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $192.58M
- Round Lot: 100
- Outstanding Shares: 12.43M
- Asset Type: CS
RECENT FILINGS FOR FBRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-09-30 | S-8 | View |
| 2025-09-05 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | SCHEDULE 13G/A | View |
| 2025-08-04 | SCHEDULE 13G/A | View |
| 2025-07-08 | SCHEDULE 13G | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-06-25 | 424B5 | View |
| 2025-06-25 | 8-K | View |
| 2025-06-24 | 424B5 | View |
| 2025-06-23 | 8-K | View |
| 2025-05-30 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on FBRX